3Sairanen T, Strbian D, Soinne L, et al. Intravenous thrombo- lysis of basilar artery occlusion predictors of recanalization and outcome[J]. Stroke,2011,42(8) :2175-2179.
4Philipps J,Thomalla G,Glahn J,et al. Treatment of progressive stroke with Tirofiban-experience in 35 patients[J]. Cerebrovasc Dis, 2009,28 (5) :435-438.
5Seitz RJ,Hamzavi M,Junghans U,et al. Thrombolysis with reco- mbinant tissue plasmingogen activator and Tirofiban in stroke: Preliminary observations[J]. Stroke,2003,34(8):1932-1935.
6Siebler M,Hennerici MG,Schneider D,et al. Safety of Tirofihan in acute ischemic stroke:the SaTIS trial[Jl. Stroke,2011,42 (9) : 2388-2392.
7Kim JII, Jeong MH, Rhew JY, et al. Long-term clinical outcomes of platelet glycoprotein Ⅱb/Ⅲa inhibitor combined with low molecular weight heparin in patients with acute coronary syndrome. Circ J, 2005, 69: 159-164.
8Dubois CL, Behnans A, Granger CB, et al. ASSENT -3 Investigators. Outcome of urgent and elective percutaneous coronary interventions after phannacologic reperfusion with tenecteplase combined with unfractionated heparin, enoxaparin, or abciximab. J Am Coil Cardiel, 2003,42: 1178-1185.
9Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) investigators. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST -segment elevation acute myocardial infarction (ASSENT -4 PCI): randomised trial. Lancet, 2006, 367: 569-578.
10Pfefferkorn T, Holtmannspotter M, Schmidt C, et al. Drip, ship, and retrieve: cooperative recanalization therapy in acute basilar artery occlusion. Stroke, 2010, 41: 722-726.
